and LDL-Apheresis Center and the Hartford Hospital Cholesterol Management Center. Approximately 2600 charts were reviewed to identify patients receiving rosuvastatin EOD who previously had ...

Individuals with low levels of low-density lipoprotein cholesterol ... LDL-C levels and eventually disappeared entirely. At LDL-C levels below 1.4 mmol/L (55mg/dL), there was an 18% risk reduction ...

An investigational PCSK9 inhibitor with a different mechanism from existing drugs in this class has been shown to safely and ...

Lp(a) shares similarities with another lipoprotein that doctors target to reduce the risk of heart disease, known as ...

Among people with LDL-C levels below 1.8 mmol/L (<70mg/dL), statin use was associated with a 13% reduction in all-cause dementia risk and a 12% decrease in risk of Alzheimer's disease-related ...

"Among people with LDL-C levels below 1.8 mmol/L, statin use was associated with a 13% reduction in all-cause dementia risk and a 12% decrease in risk of Alzheimer’s disease-related dementia ...

After 12 weeks, patients had a 50.7% reduction in LDL cholesterol. Please watch the video at Investors.com - How To Buy Stocks: Cup-With-Handle Chart Pattern In comparison, patients given Merck's ...

A greater reduction LDL-C was seen for combo therapy; reductions also seen in all-cause mortality, major adverse CV events, stroke incidence. HealthDay News — Combination lipid-lowering therapy ...

--(BUSINESS WIRE)-- Positive results from the PURSUIT Phase IIb trial for AstraZeneca’s AZD0780 demonstrated a statistically significant low-density lipoprotein cholesterol (LDL-C) reduction ...

At 12 weeks, AZD0780 30mg taken once-daily led to a 50.7% reduction in LDL-C. Similar efficacy was observed regardless of whether trial participants received moderate- or high- intensity statin ...

Thousands of lives could be saved by combining statins with another cholesterol-lowering drug, according to new research. The largest analysis to examine the best way to lower levels of "bad" ...

The study findings indicate that statin use did not lead to a significant reduction in dementia risk in patients with LDL-C levels less than 55 mg/dL. Comparatively, among statin users with LDL- ...